New Results
SARS-CoV-2 B.1.617.2 Delta variant emergence, replication and sensitivity to neutralising antibodies
Petra Mlcochova, Steven Kemp, Mahesh Shanker Dhar, Guido Papa, Bo Meng, Swapnil Mishra, Charlie Whittaker, Thomas Mellan, Isabella Ferreira, Rawlings Datir, Dami A. Collier, Anna Albecka, Sujeet Singh, Rajesh Pandey, Jonathan Brown, Jie Zhou, Niluka Goonawardne, Robin Marwal, Meena Datta, Shantanu Sengupta, Kalaiarasan Ponnusamy, Venkatraman Srinivasan Radhakrishnan, Adam Abdullahi, Oscar Charles, Partha Chattopadhyay, Priti Devi, Daniela Caputo, Tom Peacock, Chand Wattal, Neeraj Goel, Ambrish Satwik, Raju Vaishya, Meenakshi Agarwal, The Indian SARS-CoV-2 Genomics Consortium (INSACOG), The CITIID-NIHR BioResource COVID-19 Collaboration, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Antranik Mavousian, Joo Hyeon Lee, Jessica Bassi, Chiara Silacci-Fegni, Christian Saliba, Dora Pinto, Takashi Irie, Isao Yoshida, William L. Hamilton, Kei Sato, Leo James, Davide Corti, Luca Piccoli, Samir Bhatt, Seth Flaxman, Wendy S. Barclay, Partha Rakshit, Anurag Agrawal, View ORCID ProfileRavindra K. Gupta
doi: https://doi.org/10.1101/2021.05.08.443253
Petra Mlcochova
1Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
2Department of Medicine, University of Cambridge, Cambridge, UK
Steven Kemp
1Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
2Department of Medicine, University of Cambridge, Cambridge, UK
6University College London, London, UK
Mahesh Shanker Dhar
3National Centre for Disease Control, Delhi, India
Guido Papa
4MRC – Laboratory of Molecular Biology, Cambridge, UK
Bo Meng
1Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
2Department of Medicine, University of Cambridge, Cambridge, UK
Swapnil Mishra
5Medical Research Council (MRC) Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, UK
Charlie Whittaker
5Medical Research Council (MRC) Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, UK
Thomas Mellan
5Medical Research Council (MRC) Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, UK
Isabella Ferreira
1Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
2Department of Medicine, University of Cambridge, Cambridge, UK
Rawlings Datir
1Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
2Department of Medicine, University of Cambridge, Cambridge, UK
Dami A. Collier
2Department of Medicine, University of Cambridge, Cambridge, UK
6University College London, London, UK
Anna Albecka
4MRC – Laboratory of Molecular Biology, Cambridge, UK
Sujeet Singh
3National Centre for Disease Control, Delhi, India
Rajesh Pandey
7CSIR Institute of Genomics and Integrative Biology, Delhi, India
Jonathan Brown
8Department of Infectious Diseases, Imperial College London, UK
Jie Zhou
8Department of Infectious Diseases, Imperial College London, UK
Niluka Goonawardne
8Department of Infectious Diseases, Imperial College London, UK
Robin Marwal
3National Centre for Disease Control, Delhi, India
Meena Datta
3National Centre for Disease Control, Delhi, India
Shantanu Sengupta
7CSIR Institute of Genomics and Integrative Biology, Delhi, India
Kalaiarasan Ponnusamy
3National Centre for Disease Control, Delhi, India
Venkatraman Srinivasan Radhakrishnan
3National Centre for Disease Control, Delhi, India
Adam Abdullahi
1Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
2Department of Medicine, University of Cambridge, Cambridge, UK
Oscar Charles
6University College London, London, UK
Partha Chattopadhyay
7CSIR Institute of Genomics and Integrative Biology, Delhi, India
Priti Devi
7CSIR Institute of Genomics and Integrative Biology, Delhi, India
Daniela Caputo
9NIHR Bioresource, Cambridge, UK
Tom Peacock
8Department of Infectious Diseases, Imperial College London, UK
Chand Wattal
10Sri Ganga Ram Hospital, New Delhi, India
Neeraj Goel
10Sri Ganga Ram Hospital, New Delhi, India
Ambrish Satwik
10Sri Ganga Ram Hospital, New Delhi, India
Raju Vaishya
11Indraprastha Apollo Hospital, New Delhi
Meenakshi Agarwal
12Northern Railway Central Hospital, New Delhi, India
Antranik Mavousian
13Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK
Joo Hyeon Lee
13Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK
14Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK
Jessica Bassi
15Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Chiara Silacci-Fegni
15Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Christian Saliba
15Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Dora Pinto
15Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Takashi Irie
16Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 7348551, Japan
Isao Yoshida
17Tokyo Metropolitan Institute of Public Health, Tokyo 1690073, Japan
William L. Hamilton
2Department of Medicine, University of Cambridge, Cambridge, UK
Kei Sato
18Division of Systems Virology, The Institute of Medical Science, The University of Tokyo, Tokyo 1088639, Japan
19CREST, Japan Science and Technology Agency, Saitama 3220012, Japan
Leo James
4MRC – Laboratory of Molecular Biology, Cambridge, UK
Davide Corti
15Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Luca Piccoli
15Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Samir Bhatt
4MRC – Laboratory of Molecular Biology, Cambridge, UK
20Section of Epidemiology, Department of Public Health, University of Copenhagen, Denmark
Seth Flaxman
21Department of Mathematics, Imperial College London, London, UK
Wendy S. Barclay
8Department of Infectious Diseases, Imperial College London, UK
Partha Rakshit
3National Centre for Disease Control, Delhi, India
Anurag Agrawal
7CSIR Institute of Genomics and Integrative Biology, Delhi, India
Ravindra K. Gupta
1Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
2Department of Medicine, University of Cambridge, Cambridge, UK
22Africa Health Research Institute, Durban, South Africa
Article usage
Posted July 16, 2021.
SARS-CoV-2 B.1.617.2 Delta variant emergence, replication and sensitivity to neutralising antibodies
Petra Mlcochova, Steven Kemp, Mahesh Shanker Dhar, Guido Papa, Bo Meng, Swapnil Mishra, Charlie Whittaker, Thomas Mellan, Isabella Ferreira, Rawlings Datir, Dami A. Collier, Anna Albecka, Sujeet Singh, Rajesh Pandey, Jonathan Brown, Jie Zhou, Niluka Goonawardne, Robin Marwal, Meena Datta, Shantanu Sengupta, Kalaiarasan Ponnusamy, Venkatraman Srinivasan Radhakrishnan, Adam Abdullahi, Oscar Charles, Partha Chattopadhyay, Priti Devi, Daniela Caputo, Tom Peacock, Chand Wattal, Neeraj Goel, Ambrish Satwik, Raju Vaishya, Meenakshi Agarwal, The Indian SARS-CoV-2 Genomics Consortium (INSACOG), The CITIID-NIHR BioResource COVID-19 Collaboration, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Antranik Mavousian, Joo Hyeon Lee, Jessica Bassi, Chiara Silacci-Fegni, Christian Saliba, Dora Pinto, Takashi Irie, Isao Yoshida, William L. Hamilton, Kei Sato, Leo James, Davide Corti, Luca Piccoli, Samir Bhatt, Seth Flaxman, Wendy S. Barclay, Partha Rakshit, Anurag Agrawal, Ravindra K. Gupta
bioRxiv 2021.05.08.443253; doi: https://doi.org/10.1101/2021.05.08.443253
SARS-CoV-2 B.1.617.2 Delta variant emergence, replication and sensitivity to neutralising antibodies
Petra Mlcochova, Steven Kemp, Mahesh Shanker Dhar, Guido Papa, Bo Meng, Swapnil Mishra, Charlie Whittaker, Thomas Mellan, Isabella Ferreira, Rawlings Datir, Dami A. Collier, Anna Albecka, Sujeet Singh, Rajesh Pandey, Jonathan Brown, Jie Zhou, Niluka Goonawardne, Robin Marwal, Meena Datta, Shantanu Sengupta, Kalaiarasan Ponnusamy, Venkatraman Srinivasan Radhakrishnan, Adam Abdullahi, Oscar Charles, Partha Chattopadhyay, Priti Devi, Daniela Caputo, Tom Peacock, Chand Wattal, Neeraj Goel, Ambrish Satwik, Raju Vaishya, Meenakshi Agarwal, The Indian SARS-CoV-2 Genomics Consortium (INSACOG), The CITIID-NIHR BioResource COVID-19 Collaboration, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Antranik Mavousian, Joo Hyeon Lee, Jessica Bassi, Chiara Silacci-Fegni, Christian Saliba, Dora Pinto, Takashi Irie, Isao Yoshida, William L. Hamilton, Kei Sato, Leo James, Davide Corti, Luca Piccoli, Samir Bhatt, Seth Flaxman, Wendy S. Barclay, Partha Rakshit, Anurag Agrawal, Ravindra K. Gupta
bioRxiv 2021.05.08.443253; doi: https://doi.org/10.1101/2021.05.08.443253
Subject Area
Subject Areas
- Biochemistry (9171)
- Bioengineering (6804)
- Bioinformatics (24063)
- Biophysics (12154)
- Cancer Biology (9564)
- Cell Biology (13825)
- Clinical Trials (138)
- Developmental Biology (7657)
- Ecology (11736)
- Epidemiology (2066)
- Evolutionary Biology (15540)
- Genetics (10671)
- Genomics (14358)
- Immunology (9511)
- Microbiology (22901)
- Molecular Biology (9129)
- Neuroscience (49113)
- Paleontology (357)
- Pathology (1487)
- Pharmacology and Toxicology (2583)
- Physiology (3851)
- Plant Biology (8351)
- Synthetic Biology (2301)
- Systems Biology (6205)
- Zoology (1302)